XML 45 R34.htm IDEA: XBRL DOCUMENT v3.26.3
SEGMENT INFORMATION (Tables)
9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
SCHEDULE OF SEGMENT REVENUE

The CODM examines, within each operational function, the employee salaries including the bonus and share based compensation. In addition, the CODM examines the clinical trials expenses within the research and development operations.

 

   2026   2025   2026   2025 
   Three months ended
September 30,
   Nine months ended
September 30,
 
   2026   2025   2026   2025 
Revenues   2,242    2,523    7,411    5,830 
                     
Cost of Revenues:                    
Material and Labor   1,725    1,391    5,047    3,554 
Other cost of revenues   277    268    1,126    807 
Inventory write-off   -    -    1,085    - 
Total Cost of Revenues   2,002    1,659    7,258    4,361 
                     
Research and development (R&D)                    
Payroll and Benefits   1,178    1,089    4,059    3,063 
Share based compensation   (204)   576    406    1,889 
Clinical trials   1,224    1,105    3,663    3,401 
Other R&D   1,075    865    4,203    3,175 
Total Research and development   3,273    3,635    12,331    11,528 
                     
Selling and marketing (S&M)                    
Payroll and Benefits   2,618    2,975    10,411    7,732 
Share based compensation   (649)   567    475    1,379 
Other S&M   425    850    1,909    2,203 
Total Selling and marketing   2,394    4,392    12,795    11,314 
                     
General and administrative (G&A)                    
Payroll and Benefits   1,185    1,707    4,148    5,015 
Share based compensation   801    2,351    3,267    6,051 
Other G&A   1,466    1,830    4,914    5,091 
Total General and administrative   3,452    5,888    12,329    16,157 
                     
Total Restructuring   1,074    -    1,074    - 
                     
Financial Income (expenses), net;   191    343    601    505 
Segment net loss   (9,762)   (12,708)   (37,775)   (37,025)